The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations

Farzana Kapadia, David Vlahov, Robert M. Donahoe, Gerald Friedland

Research output: Contribution to journalArticle

Abstract

From the onset of the HIV/AIDS epidemic, the use of licit and illicit drugs has been investigated for its potential impact on HIV disease progression. Findings from a large number of laboratory-based studies indicate that drug abuse may exacerbate HIV disease progression; however, epidemiological studies have shown mixed results. This article presents a review of findings from both laboratory-based and epidemiologic investigations. In addition, we provide a careful evaluation of methodological strengths and limitations inherent to both study designs in order to provide a more nuanced understanding of how these findings may complement one another.

Original languageEnglish (US)
Pages (from-to)1027-1034
Number of pages8
JournalClinical Infectious Diseases
Volume41
Issue number7
DOIs
StatePublished - Oct 1 2005

Fingerprint

Substance-Related Disorders
Disease Progression
HIV
Street Drugs
Epidemiologic Studies
Acquired Immunodeficiency Syndrome

ASJC Scopus subject areas

  • Immunology

Cite this

The role of substance abuse in HIV disease progression : Reconciling differences from laboratory and epidemiologic investigations. / Kapadia, Farzana; Vlahov, David; Donahoe, Robert M.; Friedland, Gerald.

In: Clinical Infectious Diseases, Vol. 41, No. 7, 01.10.2005, p. 1027-1034.

Research output: Contribution to journalArticle

@article{e017dcb19486464184d1dc5a4f31736d,
title = "The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations",
abstract = "From the onset of the HIV/AIDS epidemic, the use of licit and illicit drugs has been investigated for its potential impact on HIV disease progression. Findings from a large number of laboratory-based studies indicate that drug abuse may exacerbate HIV disease progression; however, epidemiological studies have shown mixed results. This article presents a review of findings from both laboratory-based and epidemiologic investigations. In addition, we provide a careful evaluation of methodological strengths and limitations inherent to both study designs in order to provide a more nuanced understanding of how these findings may complement one another.",
author = "Farzana Kapadia and David Vlahov and Donahoe, {Robert M.} and Gerald Friedland",
year = "2005",
month = "10",
day = "1",
doi = "10.1086/433175",
language = "English (US)",
volume = "41",
pages = "1027--1034",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - The role of substance abuse in HIV disease progression

T2 - Reconciling differences from laboratory and epidemiologic investigations

AU - Kapadia, Farzana

AU - Vlahov, David

AU - Donahoe, Robert M.

AU - Friedland, Gerald

PY - 2005/10/1

Y1 - 2005/10/1

N2 - From the onset of the HIV/AIDS epidemic, the use of licit and illicit drugs has been investigated for its potential impact on HIV disease progression. Findings from a large number of laboratory-based studies indicate that drug abuse may exacerbate HIV disease progression; however, epidemiological studies have shown mixed results. This article presents a review of findings from both laboratory-based and epidemiologic investigations. In addition, we provide a careful evaluation of methodological strengths and limitations inherent to both study designs in order to provide a more nuanced understanding of how these findings may complement one another.

AB - From the onset of the HIV/AIDS epidemic, the use of licit and illicit drugs has been investigated for its potential impact on HIV disease progression. Findings from a large number of laboratory-based studies indicate that drug abuse may exacerbate HIV disease progression; however, epidemiological studies have shown mixed results. This article presents a review of findings from both laboratory-based and epidemiologic investigations. In addition, we provide a careful evaluation of methodological strengths and limitations inherent to both study designs in order to provide a more nuanced understanding of how these findings may complement one another.

UR - http://www.scopus.com/inward/record.url?scp=25444495620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444495620&partnerID=8YFLogxK

U2 - 10.1086/433175

DO - 10.1086/433175

M3 - Article

C2 - 16142670

AN - SCOPUS:25444495620

VL - 41

SP - 1027

EP - 1034

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 7

ER -